Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.184 EUR | +1.17% | -4.05% | -10.27% |
05-29 | Sales in Milan; but Philogen is at annual peak | AN |
05-29 | Milan opens in red; new grits for MPS | AN |
Sales 2024 * | 3.19B 3.45B 4.71B | Sales 2025 * | 3.49B 3.78B 5.16B | Capitalization | 11.03B 11.96B 16.29B |
---|---|---|---|---|---|
Net income 2024 * | 420M 455M 621M | Net income 2025 * | 483M 524M 714M | EV / Sales 2024 * | 4.21 x |
Net Debt 2024 * | 2.38B 2.59B 3.52B | Net Debt 2025 * | 2.22B 2.41B 3.28B | EV / Sales 2025 * | 3.8 x |
P/E ratio 2024 * |
26.4
x | P/E ratio 2025 * |
23.3
x | Employees | - |
Yield 2024 * |
0.76% | Yield 2025 * |
0.8% | Free-Float | 44.11% |
Latest transcript on Davide Campari-Milano N.V.
1 week | -4.05% | ||
1 month | -2.55% | ||
3 months | -1.78% | ||
6 months | -8.12% | ||
Current year | -10.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 23-09-13 | |
Director of Finance/CFO | 57 | 96-12-31 | |
Fabio di Fede
BRD | Director/Board Member | 51 | 99-05-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 57 | 96-12-31 | |
Luca Garavoglia
CHM | Chairman | 55 | 94-09-18 |
Director/Board Member | 57 | 05-09-30 |
Date | Price | Change |
---|---|---|
24-05-31 | 9.184 | +1.17% |
24-05-30 | 9.078 | -0.50% |
24-05-29 | 9.124 | -2.94% |
24-05-28 | 9.4 | -1.57% |
24-05-27 | 9.55 | -0.23% |
Real-time BOERSE MUENCHEN, May 31, 2024 at 03:43 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.49% | 286B | |
+4.55% | 78.63B | |
+4.60% | 40.65B | |
-2.55% | 35.54B | |
-15.08% | 19.41B | |
+7.69% | 16.01B | |
+3.73% | 9.86B | |
+8.80% | 9.13B | |
+4.95% | 7.69B |
- Stock Market
- Equities
- CPR Stock
- 58H Stock